We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+6.3%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$31.9B
AUM Growth
+$1.95B
(+6.5%)
Cap. Flow
+$433M
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
19.72%
Holding
2,075
New
328
Increased
694
Reduced
841
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$152M |
| 2 |
Ventas
VTR
|
+$139M |
| 3 |
Williams Companies
WMB
|
+$122M |
| 4 |
Healthpeak Properties
DOC
|
+$100M |
| 5 |
Chevron
CVX
|
+$78.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$276M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$110M |
| 3 |
Fortune Brands Innovations
FBIN
|
+$84.2M |
| 4 |
AGN
Allergan Inc
AGN
|
+$73.4M |
| 5 |
Morgan Stanley
MS
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.93% |
| 2 | Consumer Staples | 12.47% |
| 3 | Energy | 12.35% |
| 4 | Financials | 8.98% |
| 5 | Utilities | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPWR
1051
DELISTED
COMPUWARE CORP
CPWR
| $1.5M | ﹤0.01% |
156,327
+58,979
| +61% | +$575K |
|
|
1052
AstraZeneca
AZN
$253B
| $1.49M | ﹤0.01% |
20,000
-3,818,900
| -99% | -$276M |
|
1053
Boston Scientific
BSX
$63.6B
| $1.49M | ﹤0.01% |
116,298
+71,114
| +157% | +$925K |
|
1054
Nelnet
NNI
$4.56B
| $1.49M | ﹤0.01% |
35,841
+188
| +0.5% | +$7.7K |
|
1055
Zurn Elkay Water Solutions
ZWS
$7.61B
| $1.49M | ﹤0.01% |
109,544
-24,557
| -18% | -$326K |
|
1056
Novartis
NVS
$264B
| $1.48M | ﹤0.01% |
18,195
+9,016
| +98% | +$709K |
|
|
CLC
1057
DELISTED
Clarcor
CLC
| $1.47M | ﹤0.01% |
23,822
-7,183
| -23% | -$415K |
|
|
WEB
1058
DELISTED
Web.com Group, Inc.
WEB
| $1.47M | ﹤0.01% |
50,990
-5,627
| -10% | -$185K |
|
|
TMH
1059
DELISTED
Team Health Holdings Inc
TMH
| $1.47M | ﹤0.01% |
29,419
+289
| +1% | +$14K |
|
1060
Asbury Automotive
ABG
$3.5B
| $1.46M | ﹤0.01% |
21,242
-494
| -2% | -$30.5K |
|
|
POLY
1061
DELISTED
Plantronics, Inc.
POLY
| $1.46M | ﹤0.01% |
30,330
+10,639
| +54% | +$474K |
|
1062
GATX Corp
GATX
$6.27B
| $1.44M | ﹤0.01% |
21,567
-707
| -3% | -$46.2K |
|
1063
Eastman Chemical
EMN
$7.44B
| $1.44M | ﹤0.01% |
16,475
+6,535
| +66% | +$568K |
|
1064
Generac Holdings
GNRC
$10.3B
| $1.44M | ﹤0.01% |
29,473
-23,170
| -44% | -$1.22M |
|
1065
Franco-Nevada
FNV
$50B
| $1.44M | ﹤0.01% |
25,000
| – | – |
|
1066
Moody's
MCO
$80.6B
| $1.43M | ﹤0.01% |
16,306
-24,818
| -60% | -$2.04M |
|
1067
Wendy's
WEN
$1.34B
| $1.42M | ﹤0.01% |
166,843
-5,215
| -3% | -$43.9K |
|
1068
Penske Automotive Group
PAG
$14.1B
| $1.42M | ﹤0.01% |
28,686
-8,396
| -23% | -$383K |
|
|
ATW
1069
DELISTED
Atwood Oceanics
ATW
| $1.42M | ﹤0.01% |
27,049
-12,664
| -32% | -$624K |
|
1070
Enviri
NVRI
$578M
| $1.4M | ﹤0.01% |
52,537
-3,874
| -7% | -$99K |
|
1071
Hyster-Yale Materials Handling
HY
$601M
| $1.4M | ﹤0.01% |
15,789
-212
| -1% | -$19.2K |
|
|
DF
1072
DELISTED
Dean Foods Company
DF
| $1.4M | ﹤0.01% |
79,291
+16,117
| +26% | +$264K |
|
1073
WaFd
WAFD
$2.43B
| $1.39M | ﹤0.01% |
62,086
-523
| -0.8% | -$11.4K |
|
|
SYA
1074
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $1.39M | ﹤0.01% |
61,175
+867
| +1% | +$18.2K |
|
|
BAS
1075
DELISTED
Basis Energy Services, Inc.
BAS
| $1.39M | ﹤0.01% |
84
+78
| +1,300% | +$1.19M |
|
Similar funds
Federated Hermes's Q2 2014 Portfolio in Review
As of Q2 2014, Federated Hermes held 2,075 positions worth $31.9B, up 6.5% from $29.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Federated Hermes's Q2 2014 filing shows 328 new, 694 increased, 841 reduced and 117 closed positions. Its largest new stake was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M. The largest sale was AstraZeneca, an estimated $276M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.
- Federated Hermes's largest Q2 2014 buy was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M.
- Federated Hermes added most to Illumina in Q2 2014, an estimated $152M increase.
- Federated Hermes's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $276M.
- Federated Hermes fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q2 2014, selling an estimated $39.7M.
- Federated Hermes's ten largest holdings make up 20% of its $31.9B portfolio in Q2 2014.
- Federated Hermes opened 328 new positions and closed 117 in Q2 2014.
- Federated Hermes's portfolio value rose 6.5% quarter-over-quarter to $31.9B.
Based on Federated Hermes's 13F filing for Q2 2014, filed 7 Aug 2014.